AbbVie announced it will present 27 abstracts across its dermatology portfolio, including new analyses evaluating the safety and efficacy of RINVOQ® in atopic dermatitis and new data on SKYRIZI® in psoriasis and psoriatic arthritis, at the 30th European Academy of Dermatology and Venereology (EADV) Congress, to be held virtually on September 29-October 2. Learn more
Skin cancer affects people of all colors, so it is important to get to know your skin type, protect it from the sun, check yourself monthly and see a dermatologist once a year for a full body exam. Learn more
Good habits, practiced daily, can make all the difference in your life. View the 13 life rules to keep you motivated.
View 14 Things Every Teenage Should Know About Acne Infographic.
Hidradenitis Suppurativas is beginning to come to the forefront of dermatologic research, bringing a much-needed concentration to a long underrecognized and undertreated disease. Read more >
Urticaria is one of the most common skin manifestations reported in patients with coronavirus disease 2019 (COVID-19), with more than half of urticarial rashes occurring before or during classic symptoms of COVID-19, according to research data published in Dermatologic Therapy. Based on findings from this review, the presence of urticarial rashes coupled with “fever should… Read More
Some positive news has emerged this year highlighting emerging acne and rosacea treatment options. Driven by the increased demand for prescription treatments for both conditions, medications containing newly developed molecules, new combinations of old molecules, and entirely new formulations have been gaining traction. Included in these medications is the first retinoid to earn approval by… Read More
Impacting between 10-30% of people worldwide, Atopic Dermatitis is one of the most common inflammatory skin conditions. Mainly impacting children and adolescence, some of the symptoms experienced are very disruptive and include xerosis, pruritus, and lichenified plaques in flexor surfaces. To learn more about Adolescent Atopic Dermatitis we recommend reading this article put together by… Read More
The National Rosacea Society (NRS) designates April as Rosacea Awareness Month to educate the public on the impact of this chronic and widespread facial disorder that is estimated to affect more than 16 million Americans. The goal of Rosacea Awareness Month is to spread public education on this disease so that more people who may… Read More
A recent prediction from industry analysts shows the Atopic Dermatitis space might see some new life in the months ahead. With multiple promising treatments either soon to be submitted for or pending final regulatory approval, the current top treatment Dupixent by Regeneron and Sanofi looks to finally face some competition. With over 200 million adults… Read More